Public recall detail

AG-Telmisartan tablet: Overweight & Underweight tablets

2024-09-09

medium
Recall Safety notice
Quick summary

Quick summary: AG-Telmisartan tablet: Overweight & Underweight tablets. Date: 2024-09-09.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: AG-Telmisartan tablet: Overweight & Underweight tablets. Date: 2024-09-09.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandAngita
ProductAG-Telmisartan 40 mg & 80 tablet
IssueHealth products - Product quality
Recall classType II
IdentificationRA-76021

Affected products

BrandAngita
ProductAG-Telmisartan 40 mg tablet
DIN / NPN / authorizationDIN 02484536
Dosage formTablet
StrengthTelmisartan 40 mg
LotEG23AGI001, EG23AGI002, EG23AGI003, EG23AGD001, EG23AGD002, EG23AGD003
BrandAngita
ProductAG-Telmisartan 80 mg tablet
DIN / NPN / authorizationDIN 02484544
Dosage formTablet
StrengthTelmisartan 80 mg
LotEG22AGE002, EG23AGE001, EG23AGE002, EG23AGE004, EG23AGE005, EG23AGJ001, EG23AGJ002, EG23AGJ003

Issue

Affected lots may contain overweight or underweight tablets.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesANGITA PHARMA INC. 1310 Rue Nobel, Boucherville, QC J4B 5H3
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-76021
Background{}
CompaniesANGITA PHARMA INC. 1310 Rue Nobel, Boucherville, QC J4B 5H3
AudiencesGeneral public Healthcare Industry
Source updated2024-09-09

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...